MX9205186A - Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona - Google Patents

Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona

Info

Publication number
MX9205186A
MX9205186A MX9205186A MX9205186A MX9205186A MX 9205186 A MX9205186 A MX 9205186A MX 9205186 A MX9205186 A MX 9205186A MX 9205186 A MX9205186 A MX 9205186A MX 9205186 A MX9205186 A MX 9205186A
Authority
MX
Mexico
Prior art keywords
hydroxiphenyl
fenyl
triazo
ona
piperazinyl
Prior art date
Application number
MX9205186A
Other languages
English (en)
Inventor
Jan Heeres
Joseph Hector Mostmans
Johan Rene Mark Beetens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9205186A publication Critical patent/MX9205186A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9205186A 1991-09-13 1992-09-11 Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona MX9205186A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91202351 1991-09-13

Publications (1)

Publication Number Publication Date
MX9205186A true MX9205186A (es) 1993-03-01

Family

ID=8207873

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205186A MX9205186A (es) 1991-09-13 1992-09-11 Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona

Country Status (15)

Country Link
US (1) US5254553A (es)
EP (1) EP0532091A1 (es)
JP (1) JPH05194436A (es)
KR (1) KR930006009A (es)
CN (1) CN1071420A (es)
AU (1) AU652069B2 (es)
BG (1) BG96815A (es)
CA (1) CA2076257A1 (es)
FI (1) FI923723A (es)
HU (1) HUT62884A (es)
IL (1) IL102863A (es)
MX (1) MX9205186A (es)
NO (1) NO923532L (es)
NZ (1) NZ244297A (es)
ZA (1) ZA926967B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW279864B (es) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
NZ283346A (en) * 1994-04-06 1997-05-26 Janssen Pharmaceutica Nv Ester and carbamate derivatives of di- and tri-azolones; medicaments; intermediates
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones
US5607932A (en) * 1994-07-12 1997-03-04 Janssen Pharmaceutica N.V. Heterocyclic derivatives of azolones
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
RS54112B1 (en) * 2010-10-01 2015-12-31 Taisho Pharmaceutical Co. Ltd DERIVAT 1,2,4-TRIAZOLONA
KR101715448B1 (ko) * 2014-07-16 2017-03-20 주식회사 큐리언트 염증성 질환 치료용 화합물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols

Also Published As

Publication number Publication date
KR930006009A (ko) 1993-04-20
BG96815A (bg) 1993-12-24
JPH05194436A (ja) 1993-08-03
AU2281992A (en) 1993-03-18
AU652069B2 (en) 1994-08-11
US5254553A (en) 1993-10-19
NZ244297A (en) 1994-03-25
HU9202914D0 (en) 1992-11-30
IL102863A (en) 1996-05-14
EP0532091A1 (en) 1993-03-17
IL102863A0 (en) 1993-01-31
NO923532D0 (no) 1992-09-11
HUT62884A (en) 1993-06-28
ZA926967B (en) 1994-03-11
CA2076257A1 (en) 1993-03-14
NO923532L (no) 1993-03-15
FI923723A (fi) 1993-03-14
FI923723A0 (fi) 1992-08-19
CN1071420A (zh) 1993-04-28

Similar Documents

Publication Publication Date Title
FI933804A0 (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid
NL193283B (nl) 4,4-Dialkyl-1-[4-[4-(2-pirimidinyl)-1-piperazinyl]-butyl]-2,6- piperazinedionen.
DE69226449T2 (de) 2-(2,6-difluorphenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-axazoline
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
MA24171A1 (fr) Dihydrates de mesylate de 5- (2- (4-(1,2-benzisothiazole-3-yl) -1-piperazinyl)ethyl) -6-chloro-1,3-dihydro-2h-indole-2-one
DK0842143T5 (da) 2-(4-substituerede)-benzylamino-2-methyl-propanamid derivater
NO180445C (no) 2-(4-hydroksypiperidino)-1-alkanol-derivater som anti-iskemiske midler
BE895505A (fr) 2- (4- ((4,4-dialcoyl-2,6-piperidinedione-1-yl) butyl) -1-piperazinyl) pirydines
DK151489A (da) 2,3,4,-substituerede imidazoler og 3,4,5-substituerede 1,2,4-triazoler, deres fremstilling og laegemidler indeholdende forbindelserne
MX9205186A (es) Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona
NO308537B1 (no) Antipsykotiske 4-(1H-indol-1-yl)-piperidinylderivater
DE69231883T2 (de) 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
DE69430905D1 (de) 4-(R)-1'-Formylethyl Azetidin-2-on-Derivate
NO933170D0 (no) Heterocykliske forbindelser
FI923392A (fi) Foerfarande foer framstaellning av 2-(imidazol-1-yl)-2-bensyletylidenaminoxialkansyraderivat
NZ235455A (en) 2-(1,3-dioxan-2-yl)-4,5-diphenylimidazole derivatives and pharmaceutical compositions
NO930844D0 (no) 2-(2-substituerte pyrrolidinyltio)karbapenem-derivater
NZ301453A (en) 4-(substituted phenyl),4-(substituted carboxyl, carboxylamide or alkyl)-cyclohexan-1-one derivatives and medicaments
NZ243552A (en) 2-[2-(4-methoxy-2-pyridinyl)phenylsulphinyl]-1h-benzimidazole derivatives, preparation and pharmaceutical compositions thereof
ITMI910557A0 (it) Composti eterociclici